AAAAAA

   
Results: 1-10 |
Results: 10
IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis
Authors: Woods, JM Katschke, KJ Volin, MV Ruth, JH Woodruff, DC Amin, MA Conners, MA Kurata, H Arai, KI Haines, GK Kumar, P Kock, AE
Citation: Jm. Woods et al., IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis, J IMMUNOL, 166(2), 2001, pp. 1214-1222
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis
Authors: Ruth, JH Volin, MV Haines, GK Woodruff, DC Katschke, KJ Woods, JM Park, CC Morel, JCM Koch, AE
Citation: Jh. Ruth et al., Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis, ARTH RHEUM, 44(7), 2001, pp. 1568-1581
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint
Authors: Koch, AE Volin, MV Woods, JM Kunkel, SL Connors, MA Harlow, LA Woodruff, DC Burdick, MD Strieter, RM
Citation: Ae. Koch et al., Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint, ARTH RHEUM, 44(1), 2001, pp. 31-40
Fractalkine: A novel angiogenic chemokine in rheumatoid arthritis
Authors: Volin, MV Woods, JM Amin, MA Connors, MA Harlow, LA Koch, AE
Citation: Mv. Volin et al., Fractalkine: A novel angiogenic chemokine in rheumatoid arthritis, AM J PATH, 159(4), 2001, pp. 1521-1530
Cell cycle implications in the pathogenesis of rheumatoid arthritis
Authors: Volin, MV Koch, AE
Citation: Mv. Volin et Ae. Koch, Cell cycle implications in the pathogenesis of rheumatoid arthritis, FRONT BIOSC, 5, 2000, pp. D594-D601
Le(y)/H: An endothelial-selective, cytokine-inducible, angiogenic mediator
Authors: Halloran, MM Carley, WW Polverini, PJ Haskell, CJ Phan, S Anderson, BJ Woods, JM Campbell, PL Volin, MV Backer, AE Koch, AE
Citation: Mm. Halloran et al., Le(y)/H: An endothelial-selective, cytokine-inducible, angiogenic mediator, J IMMUNOL, 164(9), 2000, pp. 4868-4877
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis
Authors: Szekanecz, Z Halloran, MM Volin, MV Woods, JM Strieter, RM Haines, GK Kunkel, SL Burdick, MD Koch, AE
Citation: Z. Szekanecz et al., Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis, ARTH RHEUM, 43(6), 2000, pp. 1266-1277
Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxisin rheumatoid arthritis
Authors: Tokuhira, M Hosaka, S Volin, MV Haines, GK Katschke, KJ Kim, S Koch, AE
Citation: M. Tokuhira et al., Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxisin rheumatoid arthritis, ARTH RHEUM, 43(5), 2000, pp. 1122-1133
The role of an epithelial neutrophil-activating peptide-78-like protein inrat adjuvant-induced arthritis
Authors: Halloran, MM Woods, JM Strieter, RM Szekanecz, Z Volin, MV Hosaka, S Haines, GK Kunkel, SL Burdick, MD Walz, A Koch, AE
Citation: Mm. Halloran et al., The role of an epithelial neutrophil-activating peptide-78-like protein inrat adjuvant-induced arthritis, J IMMUNOL, 162(12), 1999, pp. 7492-7500
Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis
Authors: Volin, MV Harlow, LA Woods, JM Campbell, PL Amin, MA Tokuhira, M Koch, AE
Citation: Mv. Volin et al., Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis, ARTH RHEUM, 42(9), 1999, pp. 1927-1935
Risultati: 1-10 |